Use of MHT in women with cardiovascular disease: a systematic review and meta-analysis
This study confirms no benefit of MHT for secondary CVD prevention, highlighting evidence limitations and the importance of shared decision-making when managing menopausal symptoms in women with CVD.PMID:37933495 | DOI:10.1080/13697137.2023.2273524
Source: Climacteric - Category: Geriatrics Authors: S Bontempo L Yeganeh R Giri A J Vincent Source Type: research
More News: Angiography | Cardiology | Cardiovascular | Databases & Libraries | Estradiol | Geriatrics | Heart | Heart Attack | Heart Failure | Hormonal Therapy | Hormones | Ischemic Stroke | Men | Menopause | Stroke | Study | Women